Company profile: Inke
1.1 - Company Overview
Company description
- Provider of high-quality active pharmaceutical ingredients (APIs) with sophisticated synthesis procedures, primarily for respiratory and central nervous system (CNS) therapies, including specialized inhalation APIs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Inke
Biosynth
HQ: Switzerland
Website
- Description: Provider of critical raw materials and services to the pharmaceutical and diagnostics industries, offering custom synthesis and manufacturing services. Focused on consolidating the fragmented supply chain to improve availability and reduce time-to-market for new therapies and diagnostic assays, increasing industry productivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosynth company profile →
Clinvest Research
HQ: United States
Website
- Description: Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinvest Research company profile →
Coldchain Tech
HQ: United States
Website
- Description: Provider of cold chain management solutions for temperature-sensitive products, including VIP Shipping Systems with customizable -40°C to +70°C control; Sentry Monitoring Technology for 24/7 real-time tracking and compliance; emergency preparedness logistics and packaging; reusable thermal shippers; end-to-end fulfillment services; and SHIP2Q for hygienic, sustainable transport with component reuse.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coldchain Tech company profile →
MD Biosciences
HQ: United States
Website
- Description: Provider of discovery- and clinical-stage pharmaceutical and biotechnological services, including CLIA-certified clinical laboratory testing such as cancer mutational testing; preclinical lab services with biomarker studies, histology/IHC, and cell-based assays; biomarker analysis; and animal and cellular disease models for fibrosis, arthritis, cancer, dermal/skin conditions, immune response, metabolic diseases, IBD, respiratory diseases, and sepsis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MD Biosciences company profile →
Mithra Pharmaceuticals
HQ: Belgium
Website
- Description: Provider of women's health care products focused on contraception, fertility, and menopause. Pipeline centers on an Estetrol (E4) platform with lead development candidates Estelle, a fifth-generation oral contraceptive, and Donesta, a next-generation hormone therapy for menopausal symptoms. Portfolio also includes the Myring contraceptive vaginal ring, Tibelia for menopause, and Zoreline biodegradable implants for hormone-dependent cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mithra Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Inke
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inke
2.2 - Growth funds investing in similar companies to Inke
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Inke
4.2 - Public trading comparable groups for Inke
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →